Jaundice

Reading File
Finding Sources
Searching PubMed

"jaundice" AND "bilirubin"

Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Loading Image
Reading File
I now have comprehensive content from multiple authoritative textbooks. Let me compile the full response.

Jaundice

Jaundice (icterus) is the yellowish discoloration of the skin, sclera, and mucous membranes caused by accumulation of bilirubin. It becomes clinically visible when serum bilirubin rises above 2.5-3 mg/dL (normal <1 mg/dL). - Schwartz's Principles of Surgery, 11th Ed.

Bilirubin Metabolism - The Foundation

Bilirubin is produced primarily from breakdown of heme in red blood cells (and smaller amounts from myoglobin and cytochromes). Its metabolism has three phases:
PhaseWhat Happens
PrehepaticHeme converted to insoluble unconjugated (indirect) bilirubin; transported bound to albumin
IntrahepaticUnconjugated bilirubin taken up by hepatocytes and conjugated with glucuronic acid (via UGT1A1) to form water-soluble conjugated (direct) bilirubin
PosthepaticConjugated bilirubin excreted via bile ducts into duodenum; gut bacteria convert it to urobilinogen
Dysfunction at any phase causes jaundice. - Schwartz's Principles of Surgery

Classification by Phase (with Causes)

1. Prehepatic (Unconjugated Hyperbilirubinemia)

The conjugation system is overwhelmed by excess heme breakdown:
  • Hemolytic anemias (inherited: spherocytosis, G6PD deficiency, sickle cell; acquired)
    • Direct Coombs positive = immune-mediated (autoimmune, drug-induced)
    • Direct Coombs negative = non-immune (mechanical, microangiopathy, infections)
  • Ineffective erythropoiesis - thalassemia major, megaloblastic anemia (B12/folate deficiency), sideroblastic anemia, lead poisoning
  • Large hematoma resorption, massive tissue infarction
  • Albumin loss (burns, poor nutrition) - impairs unconjugated bilirubin transport to liver
Note: Hemolysis alone in a healthy liver cannot sustain bilirubin >4 mg/dL. Higher levels suggest concurrent hepatic dysfunction. - Harrison's Principles of Internal Medicine 22E

2. Intrahepatic (Hepatocellular or Cholestatic)

Unconjugated hyperbilirubinemia - conjugation defects:
ConditionMechanismNotes
Gilbert SyndromeUGT1A1 activity reduced to 10-35% of normal; also impaired uptakeCommon (up to 8% prevalence); bilirubin usually <3 mg/dL; exacerbated by fasting, stress, illness, alcohol; benign
Crigler-Najjar Type IComplete absence of UGT1A1Severe; kernicterus risk in neonates
Crigler-Najjar Type IIMarkedly reduced UGT1A1 (>100 UGT1 mutations identified)Less severe; residual enzyme activity
Physiologic neonatal jaundiceImmature UGT1A1 + enterohepatic recirculationSelf-limited; most neonates affected
Drug-inducedRifampin, probenecid, novobiocin inhibit hepatic uptakeResolves with drug cessation
HypothyroidismImpaired conjugation
Conjugated hyperbilirubinemia - excretion defects:
ConditionMechanism
Dubin-Johnson syndromeImpaired secretion of conjugated bilirubin from hepatocyte into canaliculi (MRP2 defect)
Rotor syndromeOATP1B1/1B3 deficiency; interrupts conjugated bilirubin reuptake
Viral hepatitisHepatocellular injury disrupts secretion
Alcoholic hepatitisHepatocellular injury; can mimic obstruction
Drug-induced hepatitisMany drugs - OTC agents, herbal supplements included
Primary biliary cholangitis (PBC)Immune destruction of intrahepatic bile ducts
Primary sclerosing cholangitis (PSC)Inflammatory stricturing of bile ducts
Ischemic hepatitisImpaired hepatic blood flow
SepsisEndotoxin inhibits NTCP, MRP2, BSEP function
CirrhosisCombined liver insufficiency + portal hypertension
Intrahepatic cholestasis of pregnancyThird trimester; BSEP/FIC1/MRP2/MDR3 gene polymorphisms; resolves postpartum
Acute fatty liver of pregnancyThird trimester; microvesicular steatosis; can be fatal
  • Quick Compendium of Clinical Pathology, 5th Ed.; Sleisenger & Fordtran's GI & Liver Disease

3. Posthepatic (Obstructive/Extrahepatic - Conjugated)

Obstruction preventing bile flow into the duodenum:
Intrinsic obstruction:
  • Choledocholithiasis (most common cause of extrahepatic obstruction)
  • Benign biliary strictures (post-surgical: clips, ischemia, retained stones)
  • Cholangiocarcinoma
  • Cholangitis (bacterial infection - presents with Charcot's triad: fever, RUQ pain, jaundice)
  • Papilla of Vater disorders
Extrinsic compression:
  • Pancreatic carcinoma (classic painless progressive jaundice in elderly)
  • Pancreatitis / pancreatic pseudocysts
  • Lymph node compression
  • Schwartz's Principles of Surgery 11th Ed.

Key Lab Differentiation

Lab FindingSuggests
ALP >3x ULN + transaminases <3x ULNCholestatic (obstructive)
Transaminases >3x ULN + ALP <3x ULNHepatocellular
Isolated unconjugated hyperbilirubinemia, all other LFTs normalGilbert's, hemolysis, Crigler-Najjar
Conjugated bilirubin >30% of totalExcretory defect (intrahepatic or posthepatic)
Leukocytosis + elevated amylase/lipaseBiliary obstruction / pancreatitis
Prothrombin time corrects with vitamin KCholestatic (fat-soluble vitamin malabsorption)
Prothrombin time does NOT correctHepatocellular synthetic failure
ThrombocytopeniaCirrhosis (portal hypertension, reduced thrombopoietin)
Hemolytic anemia (positive Coombs, abnormal smear)Prehepatic
  • Quick Compendium of Clinical Pathology 5th Ed.; Sleisenger & Fordtran's

Clinical Diagnostic Approach

Diagnostic algorithm for jaundice - Sleisenger & Fordtran's GI & Liver Disease
Four-step logical approach (Sleisenger & Fordtran's GI & Liver Disease):
  1. History, physical exam, and baseline labs
  2. Formulate working differential
  3. Select specialized tests to narrow possibilities
  4. Develop treatment/further testing strategy

History Clues

Suggests ObstructionSuggests Liver Disease
RUQ pain, fever, rigorsViral prodrome (anorexia, myalgias, malaise)
Prior biliary surgeryKnown hepatotoxin exposure
Older ageBlood products / injection drug use
Palpable abdominal massFamily history of liver disease

Physical Exam Clues

  • Cholangitis: fever, RUQ tenderness
  • Malignancy: painless jaundice, palpable gallbladder (Courvoisier's sign), weight loss
  • Cirrhosis: ascites, splenomegaly, spider telangiectasias, gynecomastia, caput medusae, asterixis
  • Wilson's disease: Kayser-Fleischer rings (pathognomonic)
History + physical + routine labs correctly classify jaundice as obstructive vs. non-obstructive in ~75% of cases. - Sleisenger & Fordtran's

Imaging Strategy

  • Abdominal ultrasound - first line if obstruction is suspected (checks for dilated bile ducts, stones, masses)
  • CT abdomen - better for extrahepatic masses, pancreatic pathology
  • MRCP - non-invasive biliary tree imaging; preferred when intermediate clinical suspicion
  • EUS - for distal biliary lesions, pancreatic assessment
  • ERCP - diagnostic AND therapeutic (stent placement, stone removal); used when obstruction confirmed

Special Contexts

Jaundice in Pregnancy

  • Hyperemesis gravidarum (1st trimester) - mild, self-limited
  • Intrahepatic cholestasis of pregnancy (3rd trimester) - pruritus + jaundice; resolves postpartum; gene polymorphisms in BSEP, FIC1, MRP2, MDR3
  • Acute fatty liver of pregnancy (3rd trimester) - microvesicular steatosis; can be fatal; requires urgent delivery
  • HELLP syndrome - hemolysis, elevated liver enzymes, low platelets; preeclampsia variant

Jaundice in Cirrhosis

Results from liver insufficiency (inability to excrete bilirubin). In cholestatic diseases (PBC, PSC) driving cirrhosis, biliary damage contributes additionally. Jaundice appearing in compensated cirrhosis signals the transition to decompensated cirrhosis (median survival drops from >12 years to ~1.6 years). - Goldman-Cecil Medicine

Jaundice in the Critically Ill

Broad differential: hepatic ischemia, blood transfusions, hepatotoxic drugs, parenteral nutrition, occult sepsis, renal injury. Even when clinical status improves, jaundice may lag in resolving - important not to over-investigate. - Sleisenger & Fordtran's

Neonatal Jaundice

  • Physiologic: UGT1A1 immaturity + enterohepatic recirculation of unconjugated bilirubin - peaks days 3-5, resolves by day 10-14
  • Pathologic: hemolytic disease, infection, Crigler-Najjar, metabolic disease
  • Phototherapy converts unconjugated bilirubin to water-soluble photoisomers for excretion without conjugation

Associated Symptoms

  • Pruritus - from bile salt accumulation; more prominent in cholestatic jaundice. Treated with cholestyramine, antihistamines, rifampin, opioid antagonists, gabapentin
  • Dark urine - conjugated bilirubin (water-soluble) spills into urine (bilirubinuria)
  • Pale/clay-colored stools - absent urobilinogen due to bile duct obstruction
  • Steatorrhea - fat malabsorption from absent bile in gut

Recent Evidence

Three recent reviews may be relevant:

Sources: Schwartz's Principles of Surgery 11th Ed. | Sleisenger & Fordtran's GI & Liver Disease | Harrison's Principles of Internal Medicine 22E | Goldman-Cecil Medicine | Quick Compendium of Clinical Pathology 5th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.